avaxim - pediatric -(5ml vial) suspension
sanofi pasteur limited - vaccin contre l'hépatite a, inactivé - suspension - 800unité - vaccin contre l'hépatite a, inactivé 800unité - vaccines
afluria susp. inj. i.m./s.c. ser. préremplie
seqirus gmbh - virus influenza inactivé - suspension injectable en seringue préremplie - virus influenza inactivé - influenza, inactivated, split virus or surface antigen
vaxigrip tetra susp. inj. s.c./i.m. ser. préremplie
sanofi pasteur europe s.a. - virus influenza a-h1n1 , virion fragmenté, inactivé 15 µg ha/1 dose; virus influenza b , virion fragmenté, inactivé 15 µg ha/1 dose; virus influenza a-h3n2 , virion fragmenté, inactivé 15 µg ha/1 dose; virus influenza b , virion fragmenté, inactivé 15 µg ha/1 dose - suspension injectable en seringue préremplie - virus influenza inactivé tétravalent - influenza, inactivated, split virus or surface antigen
efluelda tetra susp. inj. s.c./i.m. ser. préremplie
sanofi pasteur s.a. - virus influenza b , virion fragmenté, inactivé 60 µg ha/1 dose; virus influenza a-h1n1 , virion fragmenté, inactivé 60 µg ha/1 dose; virus influenza a-h3n2 , virion fragmenté, inactivé 60 µg ha/1 dose; virus influenza b , virion fragmenté, inactivé 60 µg ha/1 dose - suspension injectable en seringue préremplie - 60 µg ha/strain - virus influenza inactivé tétravalent - influenza, inactivated, split virus or surface antigen
circomax myco
zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologiques pour les suidés - les porcs (pour l'engraissement) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection. onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination. duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination. in addition, vaccination has been shown to reduce body weight gain losses under field conditions.
zoonotic influenza vaccine seqirus
seqirus s.r.l. - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - vaccins - active immunisation against h5 subtype of influenza a virus.
coxevac
ceva santé animale - vaccin inactivé de coxiella burnetii, souche nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.
solcotrichovac lyophilisat
meda pharmaceuticals switzerland gmbh - inactivé micro-organismes de certaines souches de lactobacillus acidophilus: l. rhamnosus (3 stämme) - lyophilisat - praeparatio cryodesiccata: inactivated micro-organisms of selected strains of lactobacillus acidophilus: l. rhamnosus (3 stämme) et l. vaginalis (3 stämme) et l. salivarius (1 stamm) et l. fermentum (1 stamm) > 7 x 10^9 u.. polygelinum, natrii chloridum, conserv.: phenolum max. 0.2 mg. solvens: aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. - immunostimulant à la trichomonase et non spécifique vaginitiden, à partir de 14 ans. ans - les vaccins
vepured
laboratorios hipra, s.a. - verotoxine 2e recombinante de e. coli - inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium, immunologicals for suidae - les cochons - l'immunisation active des porcelets à partir de l'âge de 2 jours pour prévenir la mortalité et réduire les signes cliniques de la maladie de l'œdème (causée par la vérotoxine 2e produite par e.. coli) et pour réduire la perte de gain de poids quotidien pendant la période d'engraissement face aux infections par la vérotoxine. coli jusqu'à l'abattage à partir de 164 jours.
hiprabovis somni/lkt émuls. inj. s.c. flac.
laboratorios hipra s.a. - histophilus somni, inactivé ; mannheimia haemolytica, inactivé, exempt de cellules > 2,8 elisa u/dose - emulsion injectable - histophilus somni, inactivé; mannheimia haemolytica, inactivé - inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - bovin